Top Menu

Annual Meeting

LIGHT 5: Fall 2019

Location and date to be announced. 


Retinal Laser: State of the Art

LIGHT 2018

October 25th  CHICAGO

The Palmer House

Empire Room

Registration open

New Symposia Format Announced:

What is “modern” retinal laser treatment?

Is there a role for retinal laser treatment today?

What kind? How? Why? When? 

Extended symposia with expert panelists with attendee Q&A and discussion of Diabetic Macular Edema; Central Serous; Diabetic Retinopathy / Proliferative Diabetic Retinopathy; Retinal Vein Occlusion / Other ( CME, Mac Tel, and more); Mechanisms and New Applications (dry AMD? OAG? IRD? Others?)


First Annual LIGHT Lecture:

Richard Morimoto, PhD

Northwestern University

Heat Shock Proteins: Update and therapeutic potential in chronic progressive neuroretinopathies”


Final Program

 

Coffee and Continental breakfast  7:15 – 8:10

 

Welcome and Outline of the Day  8:10-8:15 am

 

Symposium on Diabetic Macula Edema (DME)

8:15 – 10:00

 

Moderator: Stela Vujosevic, MD, PhD, University of Novara, Italy

 

OCT angiography analysis of DME following 577nm subthreshold diode micropulse laser (SDM)

Stela Vujosevic, MD, PhD, University of Novara, Italy

 

Management of DME with the Pattern Scanning Laser (PASCAL)

Daniel Lavinsky, MD, Federal University of Rio Grande do Sul in Porto Alegre, Brazil

 

Clinical management of DME with SDM (810nm) as first-choice therapy

Jeffrey K Luttrull, MD, Ventura, California

 

Management of DME with subthreshold micropulse laser mono and combination therapy

Lawrence Morse, MD, PhD, Univ. California at Davis

 

670nm red micropulse laser for DME

Tatsunori Komoto MD, Kishiko Ohkosihi, Keiji Inagaki MD, Masafumi Hamada MD. St Luke’s International Hospital, Tokyo, Japan

 

Role of laser for DME in a national eye center

Mahi Muqit, MD, PhD, Moorfields Eye Hospital, London, England

 

Navigated panmacular SDM (577nm) for DME

Carlos Orduna, MD PhD, European University of Madrid, Spain

 

Open Discussion  Q& A with panelists and attendees

 

BREAK 10:00 – 10:30

 

Symposium: Diabetic Retinopathy and Proliferative Diabetic Retinopathy 

10:30-11:45

 

Moderator: Jeffrey K Luttrull, MD, Ventura, California

 

Diabetic retinopathy: The biologic case for prevention

Stephen Sinclair, MD, Drexel University, Philadelphia

 

Long-term experience with PASCAL PRP for PDR

Mahi Moqit, MD, PhD, Moorfields Eye Hospital, London, England

 

Total Retinal laser Therapy (TRT): A laser strategy to match a retinopathy

Jeffrey K Luttrull, MD, Ventura, California

 

Laser for PDR: A bright future or no future at all?

Lawrence Morse, MD, PhD, Univ of California at Davis

 

Open Discussion with panelists and attendees

 

LUNCH in the Empire Room 11:45 – 1:00 pm

 

LIGHT LECTURE 1:00 – 1:15

“Update on heat shock proteins and potential role in the treatment of retinal neurodegenerations”

Richard Morimoto, PhD, Department of Molecular Biology, Northwestern University, Chicago

 

Symposium: Mechanisms of Action / New Laser Applications   

1:15 – 2:45 pm

 

Moderator: David Kent, MD, University of Liverpool, England and Kilkenny, Ireland

 

Subthreshold laser photocoagulation for Pachychoroid neovasculopathy

Kishiko Ohkoshi MD, Msafumi Hamada MD, St Luke’s International Hosp, Tokyo, Japan

 

Real-time, image-guided Photo-mediated Ultrasound Therapy as a novel method to selectively remove choroidal vasculature and retinal neovascularization

Yannis Paulus MD, Xinyi Xie, Yu Qin, Haonan Zhang, Wei Zhang, Xueding Wang, Xinmai Yang. Univ of Michigan Kellog Eye Center

 

Heat shock protein and Metallothionein family genes expression after sublethal micropulse laser photocoagulation in primary human retinal pigment epithelial cells

Keiji Inagaki MD, Kishiko Ohkoshi MD. St Luke’s International Hosp, Tokyo, Japan

 

Age-related macular degeneration: Inflammatory disequilibrium and potential for

therapeutic modulation

David Kent, MD, University of Liverpool, England and Kilkenny, Ireland

 

Long-term follow-up of panmacular SDM homeotrophy for chronic progressive retinopathies: dry AMD, retinitis pigmentosa and Stargardt’s disease; and the role of mesopic visual testing

Jeffrey K Luttrull, MD, Ventura, California; Stephen H Sinclair, Drexel University, Philadelphia, Pennsylvania 

 

One-year functional and anatomical outcomes after selective retina therapy with real-time feedback-controlled dosimetry in patients with intermediate age-related macular degeneration: A pilot study

Young Jung Roh MD, Young gun Park, MD. Catholic University of Korea

 

Influence of the inhibition of VEGF receptor 2 on the responses of cultured RPE cells to laser-induced sublethal hyperthermia.

Yoko Miura MD PhD, Katharina Kern PhD, Ralf Brinkmann PhD, Univ of Luebeck, Germany

 

At-large panelists

Daniel Palanker PhD, Stanford University, Palo Alto, California

Richard Morimoto Phd, Northwestern University, Chicago, Illinois

 

Open Discussion with panelists and attendees

 

BREAK 2:45 – 3:00 pm

 

Symposium: Retinal Vein Occlusion and Miscellaneous Macular Disorders

3:00 – 3:45 pm

 

Moderator: Kishiko Ohkoshi, MD, St Luke’s International Hospital, Tokyo, Japan

 

Role of subthreshold laser in treatment of retinal vein occlusions: the Japanese experience

Kishiko Ohkoshi, MD, St Luke’s International Hospital, Tokyo, Japan

 

SDM (810nm) for non-diabetic macular edema and miscellaneous maculopathies

Jeffrey K Luttrull, MD, Ventura, California

 

Clinical trial of PASCAL for idiopathic juxtafoveal microvascular telangiectasis type 2

Daniel Lavinsky, MD, Federal University of Rio Grande do Sul in Porto Alegre, Brazil

 

Open Discussion with panelists and attendees

 

Symposium on Central Serous Chorioretinopathy

3:45  – 4:40 pm

 

Moderator: Jan Keunen, MD PhD, Radboud University, Nijmegen, The Netherlands

 

Subthreshold laser treatment using Endpoint Management software for central serous chorioretinopathy with focal leakage

Masafumi Hamada MD, Kishiko Ohkoshi MD, St Luke’s International Hosp, Tokyo, Japan

 

Experience with PASCAL for chronic central serous chorioretinopathy

Daniel Lavinsky, MD, Federal University of Rio Grande do Sul in Porto Alegre, Brazil

 

Subthreshold Yellow Micropulse Laser for treatment of Chronic Central Serous Chorioretinopathy

Veeral Sheth, MD, Davis Bhagat MD, Rama Jager MD, Univ of Illinois, Chicago

 

The PLACE trial: Micropulse laser vs. photodynamic therapy for CSR

Jan Keunen, MD PhD, Radboud University, Nijmegen, The Netherlands

 

Open Discussion with panelists and attendees

 

RECEPTION 4:45 – 5:30 pm